Two groundbreaking biotechnology advances are fundamentally altering human health and food production in 2025, moving from ...

Early research shows that editing expanding trinucleotide repeats halts the lengthening process that causes neurological ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Bankrupt genetic testing company 23andMe has been sold to Regeneron Pharmaceuticals for $256 million. The deal includes ...

Researchers at SKUAST have achieved India's first gene-edited sheep using CRISPR-Cas9 technology. This breakthrough in animal ...

A biotech company has announced plans to acquire 23andMe after the genetic testing company filed for Chapter 11 bankruptcy.